A Dark Vector Cognition product

Item 6. Exhibits

3K characters. Original on sec.gov · Markdown

Item 6. Exhibits

| --- | --- |

Exhibit No.Incorporated by Reference
Exhibit DescriptionFormFile No.ExhibitFiling DateFiled By
4.01Forms of 5.800% Notes due 2025, 6.150% Notes due 2029, 6.250% Notes due 2032 and 6.900% Notes due 2052, together with an Officers’ Certificate issued November 9, 2022 setting forth the terms of the Notes8-K001-359924.111/9/22Oracle Corporation
31.01‡Rule 13a-14(a)/15d-14(a) Certification of Principal Executive and Financial Officer
32.01†Section 1350 Certification of Principal Executive and Financial Officer
101‡Interactive Data Files Pursuant to Rule 405 of Regulation S-T, formatted in Inline XBRL: (i) Condensed Consolidated Balance Sheets as of November 30, 2022 and May 31, 2022, (ii) Condensed Consolidated Statements of Operations for the three and six months ended November 30, 2022 and 2021, (iii) Condensed Consolidated Statements of Comprehensive Income (Loss) for the three and six months ended November 30, 2022 and 2021, (iv) Condensed Consolidated Statements of Stockholders’ Deficit for the three and six months ended November 30, 2022 and 2021, (v) Condensed Consolidated Statements of Cash Flows for the six months ended November 30, 2022 and 2021 and (vi) Notes to Condensed Consolidated Financial Statements
104‡The cover page from the Company’s Quarterly Report on Form 10-Q for the quarter ended November 30, 2022, formatted in Inline XBRL
‡Filed herewith.
†Furnished herewith.

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, Oracle Corporation has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

ORACLE CORPORATION
Date: December 13, 2022By:/s/ Safra A. Catz
Safra A. Catz Chief Executive Officer and Director (Principal Executive and Financial Officer)
Date: December 13, 2022By:/s/ William Corey West
William Corey West
Executive Vice President, Chief Accounting Officer (Principal Accounting Officer)

Previous: Item 1A. Risk Factors